CellTrend

CellTrend's business model is centered on providing high-level research and manufacturing services to the pharmaceutical, biotechnological, and academic sectors. Their expertise lies in bridging modern biochemistry and clinical pharmacy, leveraging an experienced team that includes pharmacists and medical doctors familiar with the rigorous requirements of drug development and application. The company maintains a strong commitment to quality, evidenced by its certifications under strict international standards, including ISO 9001:2008, ISO 13485:2003 (for medical devices), and compliance with the Canada Medical Devices Regulation (CMDR). Furthermore, CellTrend adheres to the rules of Good Manufacturing Practice (GMP), as stipulated by the FDA.

The entity's two main pillars of activity are Contract Research and the development and distribution of proprietary Immuno-Assays.

I. Products: Immuno-Assays and Diagnostic Kits

CellTrend is a key developer, producer, and distributor of antibody-based detection systems, most notably Enzyme-Linked Immunosorbent Assays (ELISAs). These assays are utilized as quick and sensitive analytical methods for the specific binding of antibodies to various analytes, serving both validated diagnostic and research purposes. If a specific kit is not commercially available for a customer's application, CellTrend offers contract production for the development of a fully customized assay.

Key Product Lines and Specializations:

• GPCR-Antibodies and Auto-Antibody Diagnostics: A cornerstone of CellTrend's offerings is the focus on G-Protein Coupled Receptor (GPCR) antibodies and associated auto-antibodies, which are critical markers for various autoimmune and systemic conditions.
  • AT1R-Antibody ELISA: A globally patented assay developed by CellTrend in 2006 for the determination of Auto-Antibodies against the Angiotensin-II-Receptor-I (AT1R). This assay is validated according to US FDA Guidance for Industry: Bioanalytical Method Validation.
  • Specialized Disease Panels: CellTrend offers unique auto-antibody panels for the diagnosis and research of complex, often debilitating, systemic conditions.
    • POTS/CFS/ME/SFN/Long-Covid Diagnostics: The company provides specialized panels, such as the Postural Orthostatic Tachycardia Syndrome (POTS) Panel, which is comprehensive, measuring autoantibodies against up to eleven markers. These markers typically include the Angiotensin II Type 1 Receptor (AT1R), Endothelin Receptor A (ETAR), Beta-1 and Beta-2 adrenergic receptors, and multiple muscarinic acetylcholine receptors (M1, M2, M3, M4, M5). The M.E. (Myalgic Encephalomyelitis) and Small Fiber Neuropathy (SFN) panels focus on relevant biomarkers like FGFR-3 and TSHDS auto-antibodies.
• Kits for Research Use Only (RUO) and In Vitro Diagnostics (IVD): A wide variety of test kits are available, including those for:
  • Transplantation monitoring.
  • Systemic Sclerosis.
  • Food analysis.

II. Services: Contract Research and Manufacturing

CellTrend operates extensively as a Contract Research Organization (CRO), specializing in sophisticated cell culture and immunochemistry services for drug development and research.

A. Cell-Based Bioassays and Cell Culture Systems

The company specializes in performing cell-based bioassays, which offer a critical intermediary system between simple enzymatic tests and controversial in vivo animal experiments. These are often complex functional tests where the study design and test systems are individually adapted to customer requirements.

• Complex Functional Assays: CellTrend's focus is on assays that model complex biological processes, including:
  • Angiogenesis testing.
  • Cell migration studies.
  • NCI60 screening (for anticancer compound efficacy).
  • Immune cell functions and cytokine secretion assays.
  • Inflammatory test systems.
• Fluorescent Cell Lines: CellTrend develops and modifies fluorescent stable cell lines. These products are crucial tools for live cell imaging studies and for in vivo tracing applications in translational and preclinical research.

B. Contract Services

CellTrend provides a range of outsourced services to support the entire development lifecycle for pharmaceuticals and other biotech products.

• Contract Research:
  • Analytical services: Analysis of customer-provided samples using their validated ELISAs and other techniques in the CellTrend laboratories.
  • Method validation and optimization.
• Contract Manufacturing:
  • Development and production of custom ELISAs for novel analytes.
  • Production service for specific reagents, such as specialized buffers or other required liquids.
• Consulting: Offering expert advice derived from their deep knowledge in modern biochemistry and clinical pharmacy to guide customer projects, particularly those involving cell culture systems and antibody-based detection.

In summary, CellTrend GmbH is a dedicated biotech entity providing both specialized diagnostic/research products, particularly in the challenging area of auto-antibody detection for systemic diseases, and high-quality, GMP-compliant contract research services, with a strong focus on cell-based bioassays in oncology and immunology. The combination of proprietary patented products and flexible CRO services solidifies its position in the life sciences sector.